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Here we discuss a recently published study from our group on how a continuous CD4 T-cell dependent immune
clearance of premalignant senescent cells, designated “senescence surveillance,” restricts liver cancer development.
Upon the aberrant activation of oncogenes
cells can either undergo apoptosis or
cellular senescence, a state of stable cell
cycle arrest.
1 Like apoptosis, cellular
senescence was shown to also represent
an important failsafe mechanism against
tumor development in vivo (reviewed
in ref. 2). While cellular senescence so
far has been regarded a solely cell intrinsic
mechanism of tumor suppression, i.e.,
suppressing tumor development through
the induction of a stable cell cycle arrest,
recent data from our laboratory suggest
that the cellular senescence program also
plays a crucial role in the induction of
immune responses against pre-cancerous
cells.
3 To mimic aberrant oncogene activa-
tion, which can occur in hepatocytes of
chronically damaged human livers, we
stably delivered oncogenic Nras
G12V into
mouse livers in vivo. Nras
G12V expression
in hepatocytes was accompanied by the
induction of a cellular senescence response.
Senescent Nras
G12V expressing hepatocytes
were found to express a myriad of cyto-
kines and chemokines, which led to the
attraction of innate as well as adaptive
immune cells. These different immune
cell populations were found in close
proximity to senescent, Nras
G12V expres-
sing hepatocytes. In accordance with the
hypothesis that attracted immune cells
could mediate the clearance of senescent
cells, time course analyses revealed a
progressive loss of Nras
G12V expressing
senescent cells within two months after
stable intrahepatic delivery of oncogenic
Nras
G12V. Importantly, all analyses were
paralleled using a Nras
G12V effector loop
mutant (Nras
G12V/D38A) incapable of signal-
ing to downstream pathways and therefore
for senescence induction. Importantly,
Nras
G12V/D38A expressing hepatocytes could
be detected long-term after intrahepatic
delivery, thus ruling out immune res-
ponses against overexpressed Nras peptide
per se. To address the significance of
the observed immune cell populations for
the clearance of senescent cells, we took
a genetic approach: Nras
G12V expressing
transposable elements were intrahepati-
cally delivered into mice harboring gene-
tically defined immune defects and the
number of Nras
G12V expressing senescent
cells was followed over time. We found
that the immune clearance of pre-cancerous
Nras
G12V expressing hepatocytes was abro-
gated in severe combined immunodefi-
cient (SCID) mice and also in CD4
knockout mice. Strikingly, the missing
immune clearance of Nras
G12V expressing
pre-cancerous cells in these mice resulted
in the development of hepatocellular carci-
nomas at later time points. Enzyme-linked
immunospot (ELISPOT) assays revealed
the presence of mutant Nras-specific
CD4 T-cells in mice harboring senescent
Nras




mice, in which induction of the cellular
senescence program is genetically dis-
abled. Collectively, our data showed that
oncogene induced senescence (OIS) plays
an important role in the induction of
specific immune responses against anti-
gens expressed in pre-cancerous cells.
Further mechanistic studies characterized
the observed CD4 T-cell response as a
Th1 type response and we found that
CD4 T-cells depended on monocytes and
freshly replenished macrophages to effi-
ciently kill senescent hepatocytes (Fig.1).
Interestingly, liver resident macrophages
(Kupffer cells) were found not to be
involved in the killing of Nras
G12V
expressing senescent hepatocytes.
Taken together, our study shows that
a continuous, CD4 T-cell mediated
immune clearance of pre-malignant
senescent cells is crucial to suppress
liver cancer development. Conversely, an
impaired immune clearance of premalig-
nant senescent hepatocytes was shown to
result in the development of liver carcino-
mas. Our study suggests that a small
subfraction of senescent hepatocytes can
escape their cell cycle arrest if there is
no immune clearance of these cells.
However, a direct demonstration of this
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7senescence escape remains subject for
future studies.
Finally we also addressed whether there
is evidence for immune surveillance of
senescent hepatocytes in humans. For this
purpose, we quantified the numbers of
senescent hepatocytes in patients under
immunosuppressive therapy (due to
organ transplantation) or in patients
with HIV infection, both conditions that
impact CD4 T-cell function. Increased
numbers of senescent hepatocytes were
found in both cohorts, thus supporting
that immune surveillance of senescent cells
also occurs in humans.
There has been a long scientific debate
regarding the significance of a T-cell
dependent immune surveillance mech-
anism of pre-cancerous cells (reviewed in
ref. 4). For example, an elegant recent
study showed that spontaneous intra-
hepatic activation of the Simian virus 40
(SV40) large T antigen did not result in
efficient immune responses against these
hepatocytes
5 but rather resulted in the
growth of liver carcinomas and tumor-
specific T cells were found to produce
TGFβ rather than IFNc. Our data may
help to resolve some of the controversy,
as it suggests that the induction of a
specific immune response against pre-
cancerous cells is dependent on an
intact cellular senescence response.
Therefore, immune surveillance against
pre-cancerous cells may occur if the
senescence program is engaged after the
occurrence of an oncogenic event.
However, if the induction of the cellular
senescence program is affected, e.g., due
to impaired p53 function or reduced
levels of p14
Arf (p19
Arf in mice), a specific
immune response against such tumor
prone cells may not occur. The fact that
SV40 is known to disable senescence
induction may explain the lack of immune
surveillance of SV40 expressing hepato-
cytes in the study by Blankenstein and
colleagues.
5
Future studies are needed to character-
ize whether immune surveillance of pre-
cancerous senescent cells also occurs in
other organs. Also, a deeper characteriza-
tion of the underlying mechanisms of
senescence surveillance, especially the
individual contribution of involved cyto-
and chemokines secreted from senescent
cells is needed. Such studies may pave
the way to eventually harness this process
for cancer prevention and therapy.
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Figure1. Clearance of pre-malignant senescent cells through a CD4 T-cell mediated immune
response. Upon the aberrant activation of oncogenes cells can either undergo apoptosis or cellular
senescence. Pre-malignant senescent hepatocytes are subject to a continuous CD4 T-cell mediated
immune clearance which is crucial for liver cancer suppression. CD4 T-cells depend on monocytes/
macrophages to execute the killing of pre-malignant senescent hepatocytes.
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